Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    EHC 2022
    AES 2022
    WSC 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Mar Tintoré

Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS 3:10
Natalizumab: a strategy for immunization to avoid delays of treatment onset in highly active MS
Mar Tintoré • 4 Nov 2022
The ECTRIMS 2022 Event for People with MS 1:53
The ECTRIMS 2022 Event for People with MS
Mar Tintoré • 4 Nov 2022
Biomarkers of disease activity and treatment response in MS 3:10
Biomarkers of disease activity and treatment response in MS
Mar Tintoré • 4 Nov 2022
Addressing PIRA and PROMs in clinical practice 1:39
Addressing PIRA and PROMs in clinical practice
Mar Tintoré • 4 Nov 2022
Key updates and research focuses at ECTRIMS 2022 7:37
Key updates and research focuses at ECTRIMS 2022
Mar Tintoré • 4 Nov 2022
Limitations of the current multiple sclerosis classification 3:14
Limitations of the current multiple sclerosis classification
Mar Tintoré • 4 Oct 2021
Relapse-independent progression in multiple sclerosis 1:50
Relapse-independent progression in multiple sclerosis
Mar Tintoré • 4 Oct 2021
Incorporating new measures to detect silent progression in multiple sclerosis 2:11
Incorporating new measures to detect silent progression in multiple sclerosis
Mar Tintoré • 4 Oct 2021
Key areas of research in multiple sclerosis 4:03
Key areas of research in multiple sclerosis
Mar Tintoré • 4 Oct 2021
Barcelona_BRS to predict long-term prognosis in MS patients 2:39
Barcelona_BRS to predict long-term prognosis in MS patients
Mar Tintoré • 4 Oct 2021
Future challenges for MS research: progressive disease 2:12
Future challenges for MS research: progressive disease
Mar Tintoré • 7 Jun 2021
S1P receptor modulators in the treatment of MS 5:31
S1P receptor modulators in the treatment of MS
Mar Tintoré • 7 Jun 2021
How to individualize MS treatment decisions? 12:15
How to individualize MS treatment decisions?
Mar Tintoré • 7 Jun 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy